Cure Parkinson’s Archives

October 5, 2026 Cure Parkinson’s and Van Andel Institute announce Dr. Esther Sammler as winner of the 2026 Tom Isaacs Award

GRAND RAPIDS, Mich. (Oct. 5, 2026) — Cure Parkinson’s and Van Andel Institute are delighted to announce Dr. Esther Sammler as the winner of the 2026 Tom…

December 10, 2025 Van Andel Institute, Cure Parkinson’s renew funding for Parkinson’s clinical trials program

GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials…

October 16, 2025 Largest-ever Parkinson’s disease clinical trial opens

LONDON (Oct. 16, 2025) — The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by…

September 15, 2025 Cure Parkinson’s and Van Andel Institute announce Professor Matthew Farrer as winner of the 2025 Tom Isaacs Award

GRAND RAPIDS, Mich. (Sept. 15, 2025) — The annual Tom Isaacs Award, jointly presented by Cure Parkinson’s and Van Andel Institute (VAI), honors…

September 25, 2024 2024 Tom Isaacs Award honors Parkinson’s expert Professor Oliver Bandmann

Grand Rapids, Mich. (Sept. 25, 2024) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce

May 29, 2024 Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of low-dose lithium in Parkinson’s disease

LONDON (May 29, 2024) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce funding for…

September 29, 2023 2023 Tom Isaacs Award honors Dr. Natasha Fothergill-Misbah

GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…

August 28, 2023 Preliminary phase 2 trial results of lixisenatide presented

Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…